Electrophysiology
AF ablation outcomes
Catheter ablation efficacy and long-term results
Emerging pathwayAlso known as: AFib ablation, pulmonary vein isolation, PVI outcomes
300
Clinical questions
29
Evidence-backed
100
Claims analyzed
Electrophysiology
Catheter ablation efficacy and long-term results
Synthesized from 29 evidence-backed clinical questions linked to this topic — 4 supporting the intervention, 3 against the intervention, 5 still contested.
Does amiodarone vs placebo improve outcomes in Cardiac Arrhythmia?
Low Certainty− Favors harmamiodarone vs placebo · Myocardial Infarction Hospitalization
11 studies (9,501 patients) provide low-certainty evidence against benefit of amiodarone for Myocardial Infarction Hospitalization in Cardiac Arrhythmia.
Does adenosine vs placebo improve outcomes in Coronary Stenosis?
Low Certainty− Favors harmadenosine vs placebo · Cardiac Output
3 studies (536 patients) provide low-certainty evidence against benefit of adenosine for Cardiac Output in Coronary Stenosis.
Does af ablation vs placebo improve outcomes in Atrial Fibrillation?
Low Certainty− Favors harmaf ablation vs placebo
2 studies (420 patients) provide low-certainty evidence against benefit of af ablation for the outcome in Atrial Fibrillation.
Does digitalis preparation vs placebo improve outcomes in Wolff-Parkinson-White Syndrome?
Low Certainty+ Favors benefitdigitalis preparation vs placebo · Cardiac Index
2 studies (42 patients) provide low-certainty evidence for benefit of digitalis preparation for Cardiac Index in Wolff-Parkinson-White Syndrome.
Does verapamil vs placebo improve outcomes in Wolff-Parkinson-White Syndrome?
Low Certainty+ Favors benefitverapamil vs placebo · Myocardial Infarction Hospitalization
2 studies (16 patients) provide low-certainty evidence for benefit of verapamil for Myocardial Infarction Hospitalization in Wolff-Parkinson-White Syndrome.
Does propranolol vs placebo improve Myocardial Infarction Hospitalization in Wolff-Parkinson-White Syndrome?
Low Certainty+ Favors benefitpropranolol vs placebo · Myocardial Infarction Hospitalization
2 studies (7 patients) provide low-certainty evidence for benefit of propranolol for Myocardial Infarction Hospitalization in Wolff-Parkinson-White Syndrome.
Does amiodarone vs placebo improve outcomes?
Insufficient~ Mixed resultsamiodarone vs placebo · Myocardial Infarction Hospitalization
52 studies (190,715 patients) provide insufficient evidence with mixed findings regarding amiodarone for Myocardial Infarction Hospitalization in this population.
Does adenosine vs placebo improve outcomes?
Insufficient~ Mixed resultsadenosine vs placebo · Left Ventricular Ejection Fraction
40 studies (30,134 patients) provide insufficient evidence with mixed findings regarding adenosine for Left Ventricular Ejection Fraction in this population.
Emerging evidence with 100 primary claims
Specific, answerable questions in this area — each with its own synthesized evidence and consensus. Open one to see the forest plot, source trials, and how the consensus has changed over time.
Does digitalis preparation vs placebo improve outcomes in Wolff-Parkinson-White Syndrome?
Low Certainty+ Favors benefitdigitalis preparation vs placebo · Cardiac Index
Does verapamil vs placebo improve outcomes in Wolff-Parkinson-White Syndrome?
Low Certainty+ Favors benefitverapamil vs placebo · Myocardial Infarction Hospitalization
VA Journal Club: Factor XI Inhibitors and Atrial Fibrillation
UCLA #bruinhearts Journal Club Section — Fri, Aug 7, 11:00 AM EDT
Test session
Synapse Team — Tue, Jun 16, 8:00 PM EDT
Sessions from public journal clubs on Synapse. RSVP to join the live discussion.
Acute procedural efficacy and safety of a novel cryoballoon for the treatment of paroxysmal atrial fibrillation: Results from the POLAR ICE study
Journal of Cardiovascular Electrophysiology — Martin C — Feb 2023
Phrenic nerve visualization: a profitable new application for intracardiac echocardiography?
EP Europace — Obergassel J — Mar 2023
Atrial Fibrillation After Cardiac Surgery
Annals of Surgery — Almassi G — Oct 1997
A Novel Amiodarone-Eluting Biological Glue for Reducing Postoperative Atrial Fibrillation
Journal of Cardiovascular Pharmacology and Therapeutics — Beckerman Z — Apr 2014
Clinical significance and risk factors for new onset and recurring atrial fibrillation following cardiac surgery - a retrospective data analysis
Follow this topic to get a weekly “what changed” evidence digest and alerts when journal clubs schedule sessions on it.
AF ablation outcomes (also known as AFib ablation, pulmonary vein isolation, PVI outcomes). Catheter ablation efficacy and long-term results
Synapse tracks 6 specific clinical questions in AF ablation outcomes, each synthesized independently from its own trial evidence. They include: "Does digitalis preparation vs placebo improve outcomes in Wolff-Parkinson-White Syndrome?"; "Does verapamil vs placebo improve outcomes in Wolff-Parkinson-White Syndrome?"; "Does propranolol vs placebo improve Myocardial Infarction Hospitalization in Wolff-Parkinson-White Syndrome?"; "Does exenatide vs placebo improve Myocardial Infarction Hospitalization in Myocardial Infarction?"; "Does amiodarone vs placebo improve outcomes in Cardiac Arrhythmia?".
As of 2026-08-14, the scientific consensus on AF ablation outcomes is emerging. Emerging evidence with 100 primary claims Based on 100 analyzed claims across Synapse's enriched corpus, the evidence shows.
This evidence brief synthesizes Synapse's enriched cardiology corpus; cite as synapsesocial.com/topics/af-ablation-outcomes.
Deterministic synthesis from Synapse's enriched corpus — 130 words. No AI-generated novel content; every figure is sourced from the underlying paper, guideline, or trial record linked on this page.
Explore every AF ablation outcomes paper on Synapse with AI-enriched clinical evidence, PICO analysis, and methodology classification.
Search AF ablation outcomes papersPowered by Synapse — AI-enriched analysis of 600,000+ peer-reviewed papers
BMC Anesthesiology — Todorov H — Dec 2017